Brown, K. K., Spinelli, J. B., Asara, J., & Toker, A. (2017). Adaptive Reprogramming of De Novo Pyrimidine Synthesis is a Metabolic Vulnerability in Triple-Negative Breast Cancer. Cancer Discov.
استشهاد بنمط شيكاغوBrown, Kristin K., Jessica B. Spinelli, John Asara, و Alex Toker. "Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer." Cancer Discov 2017.
MLA استشهادBrown, Kristin K., Jessica B. Spinelli, John Asara, و Alex Toker. "Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer." Cancer Discov 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.